loxoprofen has been researched along with Lung Diseases, Interstitial in 1 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Loxoprofen is a nonsteroidal anti-inflammatory drug used in the treatment of many diseases." | 1.43 | Loxoprofen-induced interstitial pneumonia: a case report. ( Arano, N; Jo, H; Kato, M; Kuriyama, S; Muraki, K; Nagashima, O; Sasaki, S; Sekimoto, Y; Suina, K; Takahashi, K; Tominaga, S; Yoshioka, Y, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, M | 1 |
| Sasaki, S | 1 |
| Sekimoto, Y | 1 |
| Arano, N | 1 |
| Jo, H | 1 |
| Suina, K | 1 |
| Kuriyama, S | 1 |
| Muraki, K | 1 |
| Nagashima, O | 1 |
| Yoshioka, Y | 1 |
| Tominaga, S | 1 |
| Takahashi, K | 1 |
1 other study available for loxoprofen and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Loxoprofen-induced interstitial pneumonia: a case report.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Lung Diseases, Interstitial; Phenylpr | 2016 |